HUT51901A - Process for production of new trombolitic ensimes - Google Patents

Process for production of new trombolitic ensimes

Info

Publication number
HUT51901A
HUT51901A HU873910A HU391087A HUT51901A HU T51901 A HUT51901 A HU T51901A HU 873910 A HU873910 A HU 873910A HU 391087 A HU391087 A HU 391087A HU T51901 A HUT51901 A HU T51901A
Authority
HU
Hungary
Prior art keywords
trombolitic
ensimes
new
production
trombolitic ensimes
Prior art date
Application number
HU873910A
Other languages
Hungarian (hu)
Inventor
Glenn R Larsen
Tim J Ahern
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE166087A external-priority patent/IE60017B1/en
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of HUT51901A publication Critical patent/HUT51901A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU873910A 1987-06-22 1987-07-03 Process for production of new trombolitic ensimes HUT51901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE166087A IE60017B1 (en) 1986-07-03 1987-06-22 Processes for the preparation of a thrombolytic protein having tissue plasminogen activator-type activity
ZA874680A ZA874680B (en) 1986-07-03 1987-06-29 Novel thrombolytic proteins

Publications (1)

Publication Number Publication Date
HUT51901A true HUT51901A (en) 1990-06-28

Family

ID=26319141

Family Applications (1)

Application Number Title Priority Date Filing Date
HU873910A HUT51901A (en) 1987-06-22 1987-07-03 Process for production of new trombolitic ensimes

Country Status (3)

Country Link
KR (1) KR960015610B1 (en)
HU (1) HUT51901A (en)
WO (1) WO1988010119A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
JPH0595786A (en) * 1991-10-07 1993-04-20 Green Cross Corp:The Mutant human prourokinase
CA2125403C (en) * 1991-12-16 2002-08-27 Herbert L. Heyneker Novel tissue plasminogen activator variants
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
DE3128669A1 (en) * 1981-07-20 1983-02-03 Hoechst Ag, 6000 Frankfurt "PLASMID P SVH 1 AND ITS USE"
US4670393A (en) * 1982-03-22 1987-06-02 Genentech, Inc. DNA vectors encoding a novel human growth hormone-variant protein
US4604377A (en) * 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
US4673640A (en) * 1984-04-30 1987-06-16 Biotechnica International, Inc. Regulated protein production using site-specific recombination
US4661453A (en) * 1984-06-19 1987-04-28 American Biogenetic Sciences, Inc. Production of tissue plasminogen activator factor
US4677064A (en) * 1984-11-09 1987-06-30 Cetus Corporation Human tumor necrosis factor
JPS6229975A (en) * 1985-08-01 1987-02-07 Mitsui Toatsu Chem Inc Purification of crude tpa

Also Published As

Publication number Publication date
WO1988010119A1 (en) 1988-12-29
KR960015610B1 (en) 1996-11-18
KR890701123A (en) 1989-12-19

Similar Documents

Publication Publication Date Title
HUT52560A (en) Process for production of plasmide-vectors
BG51051A3 (en) Process for production of b avermektins
HUT45193A (en) Process for production of galenicum
HUT47917A (en) Process for production of derivatives of amin-acid
HUT43846A (en) Process for production of new microlide compounds
HUT38610A (en) Process for production of //alkyl-sulphamido/-phenil/-alkyl-amins
HUT45096A (en) Process for production of l-lisine
HUT44976A (en) Process for production of chlor-gas from hydrogenchlorid
HUT37742A (en) Process for production of aril-hydroxamates
HUT51901A (en) Process for production of new trombolitic ensimes
HU913679D0 (en) Process for the production of n-alkyl-n-alkyltio-amines
CS96488A2 (en) Method of arylpiperazinyl-alkylenphenyl-heterocyclic compounds production
HUT44475A (en) Process for production of chlor-carbonic-acid-chlorids
EP0291870A3 (en) Process for the production of triglyceriden
EP0249969A3 (en) Process for production of 1-aminoauthraquinone
HUT50189A (en) Process for production of n-phosphomethil-glycin
EP0308962A3 (en) Process for production of dimethylnaphthalenes
HUT49143A (en) Process for production of d-arabinase
IE880158L (en) Improved process for the production of alkanesulphonamides
HUT46896A (en) Process for production of derivatives of substituated pirasole
HUT37124A (en) Process for production of diaminopiridins
EP0292674A3 (en) Process for the production of propinol
ZA883783B (en) Process for the production of 2-quinoxalines
HUT48573A (en) Improved process for production of anilene-fumarate
HUT44017A (en) Process for production of 3-hydroxi-methil-izokynolins